Why Japan is different
Japan’s longevity-supplement market developed earlier and more thoroughly than anywhere else, supported by domestic manufacturers, a strong retail pharmacy channel and a consumer base already accustomed to functional foods.
NMN in particular has been available at scale in Japan while other markets were still arguing about its category. The result is a buyer population that is unusually well informed, and correspondingly harder to impress with vague claims.
The labelling systems
Japan operates several parallel frameworks. FOSHU (Foods for Specified Health Uses) requires product-specific clinical substantiation and government approval. Foods with Function Claims (機能性表示食品) allows a manufacturer to notify a claim supported by published evidence without full pre-approval. Foods with Nutrient Function Claims covers established vitamins and minerals.
The practical effect is that Japanese labels often carry more specific and better-substantiated claims than equivalents elsewhere, and buyers read them expecting that specificity.
What Japanese buyers ask
The question order differs noticeably from Western markets. Provenance first: where is the strain from, who did the research, where is it manufactured. Evidence second: what method, what was measured, is it published. Format third: stability, dosing precision, whether it fits a daily routine. Price last.
This suits a documentation-first product. The answers here are: a strain recovered from Yakutian permafrost, research led by Prof. Anatoli Brouchkov at Moscow State University, comet-assay imaging as the reference method, patent WO2012060729 plus five national patents, all published openly rather than summarised.
Postbiotics in a Japanese context
Japan has a long and mainstream relationship with fermented foods and their derived compounds: natto, miso, koji, shio-koji. The concept of a beneficial fermentation-derived metabolite requires no explanation here; it is culturally ordinary.
That makes the postbiotic distinction easier to convey than in markets where "bacteria in a bottle" is the default mental model. The point that lands with a Japanese buyer is usually the stability advantage: no viability decline and a consistent dose across a long protocol.
Ordering from Japan
We ship to Japan. The process is the same as everywhere: send a request stating your country, receive a written reply within 48 hours confirming availability and price, then an invoice from our Estonian entity.
The site is available in Japanese: every page, including the documentation descriptions, is maintained in 日本語 alongside English. Order correspondence is currently handled in English.